/channels/taxonomy/term/11897/all en /channels/channels/event/mcgill-team-delivers-world-alzheimer-report-2021-journey-through-diagnosis-dementia-333157 <p>Diagnosis of dementia is still a major challenge globally, with an estimated 75% of cases still going undiagnosed and long wait times.</p> Wed, 08 Sep 2021 12:40:33 +0000 webfull 172880 at /channels /channels/channels/event/mcgill-cares-understanding-early-onset-dementia-331628 <p>Join us on聽<strong>July 7, 2021</strong>聽at noon for the next webcast in our biweekly series,聽<em><strong><a href="//www.mcgill.ca/medsimcentre/community-outreach/dementia/mcgill-cares-webcasts">黑料不打烊 Cares</a></strong></em>, designed to support </p> Tue, 22 Jun 2021 13:14:02 +0000 webfull 171252 at /channels /channels/news/kalgene-gears-manufacture-and-test-promising-alzheimer%E2%80%99s-treatment-nrc-mcgill-and-cimtec-263196 <div> <div> <div> <p>KalGene Pharmaceuticals and the National Research Council of Canada (NRC) are proud to announce the signature of an agreement worth over $1M to develop, scale up, and transfer the technology needed to manufacture a promising novel Alzheimer鈥檚 treatment in Canada that the parties have been co- developing since 2015.</p> <p>The treatment, a biologic molecule made up of a peptide that fights Alzheimer鈥檚 and an antibody-based carrier molecule designed to shuttle the peptide into the brain, is a custom- engineered therapeutic developed at NRC.</p></div></div></div> Mon, 03 Oct 2016 18:55:49 +0000 webfull 121769 at /channels